Dr. Guru P. Sonpavde, MD

  • Orlando, FL
  • Medical oncologist
NPI1083655716PAC ID7416946892
Medicare services, 2024
541
Medicare patients, 2024
173
Part D claims, 2024
1,040
Publications
429
Clinical trials
29
Practice address
601 E Rollins St, Orlando, FL 32803
Practice phone
Call (407) 303-1976
Professional email
Get professional email
Personal email
Get personal email
Mobile number
Get mobile number
Social profiles

Primary practice

AdventHealth Orlando

Hospital · Orlando, Florida

See all 5 affiliations

Find Dr. Sonpavde's professional email, personal email and mobile number

Dmand AI checks each channel through healthcare-specific waterfall enrichment. See what is on file with a free account, with practice phones, licenses and affiliations.

View contacts for free

Dr. Guru P. Sonpavde is a medical oncologist in Orlando, Florida

Dr. Sonpavde practices at AdventHealth Orlando in Orlando, Florida, part of AdventHealth.

Dr. Sonpavde's NPI, 1083655716, was assigned on June 10, 2006. Dr. Sonpavde graduated from Christian Medical College Vellore in 1990. Dr. Sonpavde holds Florida license ME154902.

NPI and contact details
Medicare PAC ID
7416946892
NPI enumeration date
June 10, 2006
NPI status
Active
Accepts Medicare assignment
Yes
Offers telehealth
Yes
Practice phone
(407) 303-1976
Professional email
Get email
Personal email
Get email
Mobile number
Get number
Sex
Male
Estimated age
62
Medical school graduation
1990

Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; Dmand AI Affiliation Data; and Doctors and Clinicians National Downloadable File (CMS)

Dr. Guru P. Sonpavde practices at AdventHealth Orlando in Orlando, Florida

Dr. Sonpavde's primary practice is AdventHealth Orlando, at 601 E Rollins St, Orlando, FL 32803 in Orange County. The practice phone is (407) 303-1976.

Source: Dmand AI Affiliation Data

Dr. Guru P. Sonpavde is affiliated with 4 sites of care and 1 medical group

Dr. Sonpavde's primary practice is AdventHealth Orlando in Orlando, Florida, part of AdventHealth. Dr. Sonpavde is also affiliated with AdventHealth Waterman. The medical group on file is AdventHealth Medical Group. Dmand AI also links Dr. Sonpavde to 1 more hospital and 1 group practice or clinic, each named with a free account.

See all 5 affiliations for Dr. Sonpavde

Sources: Dmand AI Affiliation Data; and Dmand AI Org Hierarchy Data

Dmand AI tracks the EHR system at Dr. Guru P. Sonpavde's practice

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Sonpavde practices, 4 sites in all. Vendor and product names are available with a free account.

EHR by site
SiteEHR vendor and product
AdventHealth OrlandoAvailable with a free account
+3 more affiliated sitesAvailable with a free account

Source: Dmand AI Technology Install Data

For health IT teams

See the EHR and IT leaders at every hospital where Dr. Sonpavde practices

Dmand AI maps EHR vendors, IT decision makers and buying committees across AdventHealth and 6.2K+ hospitals, with verified contacts in the same login.

Dr. Guru P. Sonpavde is one of 477 medical oncologists in Florida

Medical oncology is Dr. Sonpavde's primary specialty in the NPI Registry, under taxonomy code 207RX0202X. Dr. Sonpavde is board certified in medical oncology by the American Board of Internal Medicine. Dmand AI has Dr. Sonpavde's licenses on file in 10 states: Florida, Connecticut, Massachusetts, New Hampshire, Rhode Island, Alabama, Texas, Arizona, Tennessee and Indiana.

Specialties and state licenses

  • Medical oncology, FloridaPrimaryLicense ME154902 · 2022 to 2026 · taxonomy 207RX0202X
  • Connecticut license
  • Hematology (internal medicine), MassachusettsLicense 271600 · 2017 to 2024 · taxonomy 207RH0000X
  • New Hampshire license2024
  • Rhode Island license2020
  • Alabama license2012 to 2017
  • Hematology and oncology, TexasLicense L7567 · 2003 to 2013 · taxonomy 207RH0003X
  • Arizona license2001 to 2003
  • Tennessee license1999 to 2002
  • Indiana license1995 to 1999

Clinical focus

Dmand AI lists prostate cancer among the conditions Dr. Sonpavde treats.

Medical oncologists near Dr. Sonpavde

Counts of medical oncologists with a Dmand AI profile, by place and practice. Each opens the list.

Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Peer Benchmarks

Dr. Guru P. Sonpavde billed Medicare for 541 services in 2024

CMS data shows 541 Medicare services from Dr. Sonpavde across 6 procedure codes in 2024, for 173 Medicare patients. Medicare paid $36,810 for them. Every service was in an office.

Medicare services, 2024541
Medicare patients173
Paid by Medicare$36,810
Procedure codes6

Dr. Sonpavde's Medicare services by type, 2023 to 2024

  • 2023
  • 2024
Office and hospital visits
2023: 4432024: 50815%
Lab and pathology
2023: 212024: 3357%

Dr. Sonpavde compared with the Florida median for medical oncologists, 2024

  • Dr. Sonpavde
  • Florida median
Medicare services
541vs 19,75597% below
Medicare patients
173vs 54168% below
Part D claims
894vs 59849% above

Medians across 462 medical oncologists in Florida with Dmand AI profiles that report each measure.

Dr. Sonpavde's most billed Medicare procedure codes, 2024

CMS publishes codes billed for 11 or more Medicare patients. Each label is the code family; CPT descriptions are licensed by the AMA.

See all procedures by Dr. Sonpavde

Need commercial claims for Dr. Sonpavde?

Medicare shows one payer. Book a meeting to get commercial claims data for Dr. Sonpavde and other medical oncologists in Florida.

Book a meeting

Sources: Medicare Physician & Other Practitioners - by Provider and Service (CMS), 2024 data; and Dmand AI Peer Benchmarks

Dr. Guru P. Sonpavde treated 173 Medicare patients in 2024, average age 74

CMS counts 173 Medicare patients who saw Dr. Sonpavde in 2024. The largest group is 65 to 74, with 97 patients. 75% of them have cancer, and 75% have high blood pressure. Their average risk score is 1.80, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Sonpavde's median patient age at 72, with 12% women.

Medicare patients, 2024173
Average age74
Average risk score1.80

Dr. Sonpavde's Medicare patients by age, 2024

CMS leaves out age groups with fewer than 11 patients.

Dr. Sonpavde's Medicare patients by sex, 2024

  • Women1810%
  • Men15590%

Chronic conditions among Dr. Sonpavde's Medicare patients, 2024

  1. Cancer75%
  2. High blood pressure75%
  3. High cholesterol75%
  4. Ischemic heart disease44%
  5. Arthritis36%
  6. Chronic kidney disease32%
  7. Diabetes32%
  8. Atrial fibrillation22%

Share of Medicare patients with each condition. A patient can have several.

Dr. Sonpavde's patients across all payers

Dmand AI patient panel data covers Medicare, Medicaid and commercial patients.

Patient panel by age, all payers

Median age 72

Patient panel by sex, all payers

  • Women12%
  • Men87%

Sources: Dmand AI Patient Panel Data; and Medicare Physician & Other Practitioners - by Provider (CMS), 2024 data

Dr. Guru P. Sonpavde wrote 1,040 Medicare Part D claims in 2024

In 2024, Dr. Sonpavde wrote 1,040 Medicare Part D claims for 144 patients. 87% of them were for generic drugs. CMS names the drug for 894 of them, across 12 drugs with 11 or more claims each, at $1,632,918 in total drug cost. In 2023, CMS named 316 claims across 6 drugs.

Part D claims, 20241,040
Drugs named by CMS12
Total drug cost$1.6M
Part D patients144

Dr. Sonpavde's Part D claims by kind of drug, 2024

  • Generic900 claims87%
  • Brand-name140 claims13%

Dr. Sonpavde's most prescribed drugs by claims, 2024

CMS names a drug when it has 11 or more claims. Share is of the claims for drugs CMS names.

Drug classes CMS tracks in Dr. Sonpavde's Part D claims, 2024

  • Opioids3%35 of 1,040 claims
  • Antibiotics1%13 of 1,040 claims

Share of all Part D claims for each drug class CMS reports on. Classes with no claims are left out.

Part D claims for drugs CMS names, 2023 to 2024

  • 2023
  • 2024
Claims for drugs CMS names
2023: 3162024: 894183%

Drugs named by CMS: 12 in 2024, 6 in 2023.

See all prescribing by Dr. Sonpavde

Sources: Medicare Part D Prescribers - by Provider and Drug (CMS), 2024 data, released May 6, 2026; and Medicare Part D Prescribers - by Provider (CMS), 2024 data

Dr. Guru P. Sonpavde offers telehealth to Medicare patients

Dr. Sonpavde accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Sonpavde as offering telehealth.

Accepts Medicare assignment
Yes
Offers telehealth
Yes

Source: Doctors and Clinicians National Downloadable File (CMS)

For MedTech and pharma teams

Find medical oncologists like Dr. Sonpavde by procedure volume and prescribing

Filter 7.4M+ HCPs by Medicare procedures, Part D drugs and Open Payments history, then reach them with verified contacts in one login.

Dr. Guru P. Sonpavde has 429 publications on record

Dmand AI links 429 papers to Dr. Sonpavde, published from 2006 to 2025. 2021 was the busiest year, with 27. The most frequent topics are Urinary Bladder Neoplasms, Carcinoma, Transitional Cell and Antineoplastic Agents. Dr. Sonpavde has published most often in Clin Genitourin Cancer. Dr. Sonpavde's most frequent co-authors are Matthew D. Galsky, MD, Toni K. Choueiri, MD and Thomas Edgar Hutson, DO, PharmD.

Papers429
Years published2006 to 2025

Dr. Sonpavde's papers by year, 2016 to 2025

Topics Dr. Sonpavde writes about most

  • Urinary Bladder Neoplasms
  • Carcinoma, Transitional Cell
  • Antineoplastic Agents
  • Antineoplastic Combined Chemotherapy Protocols
  • Urologic Neoplasms
  • Prostatic Neoplasms
  • Neoplasm Metastasis
  • Kidney Neoplasms

Dr. Sonpavde's most frequent co-authors

Recent publications by Dr. Sonpavde

See all 429 publications and co-authors

See who Dr. Sonpavde researches with

Physician Network Discovery turns co-authorship, shared hospitals and shared groups into a map of who Dr. Sonpavde works with, so you can find a warm path to the right medical oncologists.

How network discovery works

Sources: PubMed (National Library of Medicine); and Dmand AI Research Linkage

Dr. Guru P. Sonpavde has worked on 29 clinical trials

Dmand AI links Dr. Sonpavde to 29 clinical trials, 16 of them phase 2 studies. 5 are still active or recruiting. Conditions studied include Prostatic Neoplasms, Urinary Bladder Neoplasms and Prostatic Diseases. University of Alabama at Birmingham sponsors the most, 5. Open Payments lists research payments to Dr. Sonpavde that name 3 trials.

Clinical trials with Dr. Sonpavde by phase

  1. 5Phase 1: 5 trials
  2. 5Phase 1/2: 5 trials
  3. 16Phase 2: 16 trials
  4. 2Phase 3: 2 trials
  5. NonePhase 4: no trials

Conditions in Dr. Sonpavde's trials

  • Prostatic Neoplasms
  • Urinary Bladder Neoplasms
  • Prostatic Diseases
  • Carcinoma, Renal Cell
  • Carcinoma, Transitional Cell

Investigators on the most trials with Dr. Sonpavde

Recent clinical trials with Dr. Sonpavde

See all 29 clinical trials and co-investigators

Sources: Dmand AI Research Linkage; and ClinicalTrials.gov (National Library of Medicine)

Dr. Guru P. Sonpavde received $547,408 in industry payments from 2016 to 2025

CMS Open Payments shows 594 general payments to Dr. Sonpavde from 37 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 58% of the total. Merck Sharp & Dohme Corporation paid the most, $130,185. It also lists 44 research payments totaling $27,357 from 2016 to 2025, naming 3 clinical trials.

General payments to Dr. Sonpavde by program year, 2016 to 2025

General payments to Dr. Sonpavde by kind, 2016 to 2025

$547.4Kin total
  • Consulting fees$315,67258%
  • Speaker and faculty fees$128,11224%
  • Travel and lodging$65,18012%
  • Food and beverage$21,2904%
  • Other$12,0602%

Companies that paid Dr. Sonpavde the most, 2016 to 2025

Share is of all general payments to this clinician.

See all payments to Dr. Sonpavde

Source: Open Payments (CMS), 2025 data, released July 7, 2026

Dr. Guru P. Sonpavde graduated from Christian Medical College Vellore

Dr. Sonpavde graduated from Christian Medical College Vellore in 1990. Dr. Sonpavde is a member of ASCO.

  1. Medical schoolChristian Medical College Vellore
  2. Board certified in medical oncologyAmerican Board of Internal Medicine

Source: Dmand AI Professional Profile Data

Dr. Guru P. Sonpavde accepts plans from 20 insurance carriers

Dr. Sonpavde is in network with 20 carriers, including Elevance, Aetna and Excellus BlueCross BlueShield. PPO plans come from the most carriers, 12. Check the plan with the practice before a visit.

Plan types Dr. Sonpavde accepts, by number of carriers

  1. PPO12
  2. HMO11
  3. Medicare11
  4. POS6
  5. EPO5
  6. Medicaid3

Source: Dmand AI Insurance Network Data

Sources for Dr. Guru P. Sonpavde's profile data

Sources for the data on this page
Data on this pageSource
NPI, name, sex, specialty and licensesNPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Professional Profile Data
Practice locations and phoneDmand AI Affiliation Data
Primary practice, affiliations and health systemDmand AI Affiliation DataDmand AI Org Hierarchy Data
Medicare services and procedure codesMedicare Physician & Other Practitioners - by Provider and Service (CMS) (opens in a new tab)
State medians for the same specialtyDmand AI Peer Benchmarks
Medicare patients and the all-payer patient panelDmand AI Patient Panel DataMedicare Physician & Other Practitioners - by Provider (CMS) (opens in a new tab)
Part D prescribingMedicare Part D Prescribers - by Provider and Drug (CMS) (opens in a new tab)Medicare Part D Prescribers - by Provider (CMS) (opens in a new tab)
MIPS scores, telehealth, assignment and procedure percentilesDoctors and Clinicians National Downloadable File (CMS) (opens in a new tab)
Publications, topics and co-authorsPubMed (National Library of Medicine) (opens in a new tab)Dmand AI Research Linkage
Clinical trials and co-investigatorsDmand AI Research LinkageClinicalTrials.gov (National Library of Medicine) (opens in a new tab)
Industry paymentsOpen Payments (CMS) (opens in a new tab)
Training, board certification and membershipsDmand AI Professional Profile Data
Insurance carriers and plan typesDmand AI Insurance Network Data
EHR at each practice siteDmand AI Technology Install Data
Similar physiciansDmand AI Affiliation Data

Data last refreshed October 2026Report an inaccuracyRemove my information

FAQ

Frequently asked questions about Dr. Guru P. Sonpavde

Spotted something out of date? Email hello@dmand.ai and we will check the record. Contact details live in the free trial.

What is Dr. Guru P. Sonpavde's NPI number?

Dr. Guru P. Sonpavde's NPI number is 1083655716. It was assigned on June 10, 2006, and it is active in the NPI Registry.

What kind of doctor is Dr. Guru P. Sonpavde?

Dr. Guru P. Sonpavde is a medical oncologist in Orlando, Florida. The primary specialty in the NPI Registry is Medical Oncology Physician (taxonomy code 207RX0202X).

Where does Dr. Guru P. Sonpavde practice?

Dr. Sonpavde practices at 601 E Rollins St, Orlando, FL 32803. Dr. Sonpavde's primary practice is AdventHealth Orlando in Orlando, Florida, part of AdventHealth. Dmand AI also links Dr. Sonpavde to 1 hospital and 1 group practice or clinic.

What is Dr. Guru P. Sonpavde's office phone number?

The practice phone on file for Dr. Sonpavde is (407) 303-1976.

What is Dr. Guru P. Sonpavde's medical license number?

Dr. Sonpavde holds Florida license ME154902, one of the licenses on file in 10 states.

Which states has Dr. Guru P. Sonpavde been licensed in?

Dmand AI has state licenses on file for Dr. Sonpavde in Florida (2022 to 2026), Connecticut, Massachusetts (2017 to 2024), New Hampshire (2024), Rhode Island (2020), Alabama (2012 to 2017), Texas (2003 to 2013), Arizona (2001 to 2003), Tennessee (1999 to 2002) and Indiana (1995 to 1999).

Which hospitals is Dr. Guru P. Sonpavde affiliated with?

Dr. Sonpavde practices at AdventHealth Orlando in Orlando, Florida. Dr. Sonpavde is also affiliated with AdventHealth Waterman. Dmand AI links Dr. Sonpavde to 1 more hospital.

What medical group is Dr. Guru P. Sonpavde part of?

Dr. Sonpavde is linked to AdventHealth Medical Group.

Does Dr. Guru P. Sonpavde accept Medicare?

Yes. CMS data shows Dr. Sonpavde billed Medicare for 541 services in 2024, and Dr. Sonpavde accepts Medicare assignment.

Does Dr. Guru P. Sonpavde offer telehealth?

Yes. The CMS Doctors and Clinicians file lists Dr. Sonpavde as offering telehealth services.

Show 10 more questionsShow fewer questions

How many Medicare patients does Dr. Guru P. Sonpavde see?

CMS counts 173 Medicare patients who saw Dr. Sonpavde in 2024, with an average age of 74.

Is Dr. Guru P. Sonpavde board certified?

Yes. Dr. Sonpavde is board certified in medical oncology by the American Board of Internal Medicine.

What services does Dr. Guru P. Sonpavde bill to Medicare?

In 2024, Dr. Sonpavde's most billed Medicare services were office visit, established patient (99213), office visit, established patient (99212) and office visit, established patient (99214).

Where did Dr. Guru P. Sonpavde go to medical school?

Dr. Sonpavde graduated from Christian Medical College Vellore in 1990.

What drugs does Dr. Guru P. Sonpavde prescribe most?

In 2024 Medicare Part D data, Dr. Sonpavde's most prescribed drugs by claims were Abiraterone Acetate, Alendronate Sodium and Prednisone.

Has Dr. Guru P. Sonpavde received payments from drug or device companies?

CMS Open Payments shows $547,408 in general payments to Dr. Sonpavde from 37 companies from 2016 to 2025. The largest total came from Merck Sharp & Dohme Corporation.

How long has Dr. Guru P. Sonpavde been practicing?

Dr. Sonpavde graduated from medical school in 1990, 36 years ago.

Does Dr. Guru P. Sonpavde do research?

Dmand AI links 429 publications to Dr. Sonpavde, published from 2006 to 2025. Dr. Sonpavde has worked on 29 clinical trials.

Who does Dr. Guru P. Sonpavde publish with?

Dr. Sonpavde's most frequent co-authors are Matthew D. Galsky, MD (68 shared papers), Toni K. Choueiri, MD (58 shared papers) and Thomas Edgar Hutson, DO, PharmD (28 shared papers).

What insurance does Dr. Guru P. Sonpavde accept?

Dr. Sonpavde is in network with 20 carriers, including Elevance, Aetna and Excellus BlueCross BlueShield. PPO plans come from the most carriers, 12. Check the plan with the practice before a visit.

Selling to medical oncology practices?

See medical oncologists in Florida by site of care and group

Find the practices, groups and hospitals they work with, and the right people to contact at each.

  • 30 days free
  • Self-serve
  • No credit card

Cookie settings

Turn each category on or off. Your choice is kept for 12 months and you can change it here at any time.

Necessary

Always on. Sign-in, security, downloads you asked for, your cookie choice, and the page that led to a signup.

View cookies (6)
  • dm_consentDmand AI. Your cookie choices and whether your browser sent a Global Privacy Control signal. 12 months.
  • dm_ft, dm_ltDmand AI. The first and the latest page you arrived on, with the date, so a signup is credited to the page that worked. 90 days, 30 days.
  • dm_fs, dm_lsDmand AI. The first and the latest source of a visit (a search engine, a campaign or the site that linked here). 90 days, 30 days.
  • dm_dl, dm_dl_okDmand AI. After you give an email address for a download, lets you download files without being asked again. 30 days.
  • Session and CSRF cookiesDmand AI (app.dmand.ai). Sign-in and form protection in the application. Session.
  • __cf_bm, cf_clearanceCloudflare. Tells people from automated traffic and keeps the site available. 30 minutes; cf_clearance while a security check is valid.

Analytics

On unless you turn it off. How pages are used, in aggregate, and recordings of how pages are used.

View cookies (6)
  • Google Tag ManagerGoogle. Loads the analytics and marketing tags that are on. Sets no cookie of its own and does not load when both categories are off. n/a.
  • _ga, _ga_<container-id>Google Analytics 4. Visits and page views in aggregate on dmand.ai. 2 years.
  • _clck, _clskMicrosoft Clarity. Recordings and heatmaps of how pages are used, with form fields masked. 1 year, 1 day.
  • CLID, MUID, ANONCHK, MR, SMMicrosoft (clarity.ms). Set by Microsoft when Clarity loads, to recognize a browser across sites that use Clarity. Up to 1 year.
  • None (cookieless)Ahrefs Analytics. Page views in aggregate. n/a.
  • ph_<project>_posthogPostHog. Product usage, errors and performance in app.dmand.ai, used to fix bugs and improve features. 365 days.

Marketing

On unless you turn it off, and always off when your browser sends a Global Privacy Control signal. A visitor identification service tells our sales team which companies and people visit.

View cookies (6)
  • _reb2buid, _reb2butkRB2B. Recognizes a returning browser for visitor identification. 360 days, 1 year.
  • _reb2bgeoRB2B. The location used to decide whether a visit can be identified. 20 days.
  • _reb2brefRB2B. The page or site that referred the visit. 15 days.
  • _reb2bfxf, _reb2btd, _reb2bliRB2B. Links the visit to an identified business profile. 1 month.
  • _reb2bresolveRB2B. Holds a match while it is being resolved. 2 days.
  • _reb2sessionID, _reb2bloadedRB2B. The current visit, and a guard against loading the script twice. 30 minutes, 1 second.

Functional

On unless you turn it off. Remembers choices such as a collapsed section.

View cookies (none today)